Consequently, targeting Nrf2 has emerged as an attractive therapeutic strategy for stroke prevention and reversal (Calkins et al., 2009; Leonardo and Doré, 2011; Wang Y. C. et al., 2011; Ma, 2013; Kumar et al., 2014; Tonelli et al., 2017). The gene discussed is NFE2L2; the disease is stroke disorder.